IOVA
Iovance Biotherapeutics Inc
NASDAQ: IOVA · HEALTHCARE · BIOTECHNOLOGY
$3.36
+1.51% today
Updated 2026-04-30
Market cap
$1.41B
P/E ratio
—
P/S ratio
5.36x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$2 – $6
Volume
17.4M
Iovance Biotherapeutics Inc (IOVA) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |